Back to Capital World Investors Capital World Investors

REGNREGN
29 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in REGENERON PHARMACEUTICALS

Yes. Capital World Investors holds 814,925 shares of REGN (Regeneron Pharmaceuticals), worth $508.1M, as of its Q2 2026 13F filing. It reduced the position by 604,075 shares (-42.6%) from Q1 2026. Capital World Investors has held REGN in every 13F on record since Q2 2019, 29 quarterly filings. REGN is 0.1% of Capital World Investors' reported 13F portfolio.

Current Value

$508.1M

Current Shares

814,925

Total Value Change

-$2B

Total Shares Change

-7.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
814,925
-42.6%
$508.1M0.1%$622.81
0
2026-Q1
Increased
1.4M
+1.5%
$1.1B0.1%$770.59
39
2025-Q4
Decreased
1.4M
-30.0%
$1.1B0.1%$768.90
0
2025-Q3
Increased
2M
+1.6%
$1.1B0.2%$559.40
39
2025-Q2
Increased
2M
+1.4%
$1B0.1%$521.53
39
2025-Q1
Decreased
1.9M
-30.2%
$1.2B0.2%$629.11
0
2024-Q4
Decreased
2.8M
-35.4%
$2B0.3%$705.67
0
2024-Q3
Decreased
4.3M
-7.3%
$4.5B0.7%$1,041.41
0
2024-Q2
Decreased
4.6M
-0.3%
$4.9B0.8%$1,041.20
0
2024-Q1
Decreased
4.7M
-9.3%
$4.5B0.7%$953.49
0
2023-Q4
Increased
5.1M
+0.5%
$4.5B0.8%$870.08
45
2023-Q3
Decreased
5.1M
-8.0%
$4.2B0.8%$815.27
0
2023-Q2
Decreased
5.6M
-4.8%
$4B0.8%$711.82
0
2023-Q1
Decreased
5.8M
-6.6%
$4.8B1.0%$813.99
0
2022-Q4
Increased
6.2M
+0.3%
$4.5B1.0%$714.75
45
2022-Q3
Decreased
6.2M
-0.1%
$4.3B1.0%$682.43
0
2022-Q2
Increased
6.2M
+4.8%
$3.7B0.8%$585.60
47
2022-Q1
Increased
5.9M
+11.8%
$4.2B0.7%$691.89
50
2021-Q4
Increased
5.3M
+0.1%
$3.4B0.5%$625.62
45
2021-Q3
Increased
5.3M
+0.2%
$3.2B0.5%$599.52
45
2021-Q2
Decreased
5.3M
-14.2%
$3B0.5%$553.32
0
2021-Q1
Decreased
6.2M
-11.0%
$2.9B0.5%$468.72
0
2020-Q4
Increased
6.9M
+4.5%
$3.4B0.6%$478.59
47
2020-Q3
Decreased
6.6M
-4.2%
$3.7B0.8%$554.55
0
2020-Q2
Decreased
6.9M
-2.8%
$4.3B1.0%$617.82
0
2020-Q1
Decreased
7.1M
-14.4%
$3.5B1.0%$483.73
0
2019-Q4
Increased
8.3M
+1.5%
$3.1B0.7%$371.97
46
2019-Q3
Increased
8.2M
+1.3%
$2.3B0.5%$274.81
45
2019-Q2
First report
8.1M
-
$2.5B0.6%$310.07
0

Other major holders of REGN: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used